NCT02714335View on ClinicalTrials.gov

The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Carcinoma, Non-Small-Cell Lung

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Szu-Hua Pan

OTHER

NCT02714335 - The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients | Biotech Hunter | Biotech Hunter